SELLAS Life Sciences Group, Inc. (SLS) Cash Flow Statement
SELLAS Life Sciences Group, Inc. (SLS) generated -$28.4M of operating cash flow over the twelve months to 2026-06-30, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SLSSELLAS Life Sciences Group, Inc.Follow SLS — free
—
Price chart with a free account
- Market cap
- 2.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -14.7 | -21.0 | -28.9 | -42.9 | -48.2 | -11.9 | -11.0 | -30.4 | -17.6 | -10.4 | -26.0 | -23.8 | -31.4 | -35.4 | -28.4 | -28.4 | |
| Capital expenditure | 0.1 | 0.0 | 0.3 | 0.1 | 0.2 | 0.0 | — | — | — | — | — | — | — | — | — | — | |
| Free cash flow | -14.7 | -21.0 | -29.2 | -42.9 | -48.3 | -11.9 | — | — | — | — | — | — | — | — | — | — | |
| Dividends paid | — | — | — | — | — | — | — | 0.5 | 0.0 | — | — | — | — | — | — | — | |
| Stock-based compensation | 3.0 | 1.4 | 2.3 | 4.7 | 1.9 | 0.4 | 3.2 | 0.4 | 0.6 | 0.6 | 1.0 | 1.7 | 2.1 | 1.6 | 2.0 | — |
USD millions · SEC XBRL
SELLAS Life Sciences Group, Inc. — questions
- What is SELLAS Life Sciences Group, Inc.'s operating cash flow?
- -$28.4M over the twelve months to 2026-06-30.
Every figure on this page comes from SELLAS Life Sciences Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.